Product Pipeline
BiolActis’ products have the advantages of being natural, causing no side effects while exhibiting health benefits comparable to established drugs such as niacin, hydrocortisone, 5-ASA, lovastatin and ibuprofen. The development and growth plan focuses on the marketing of novel health products supported by strong scientific evidence inspired by the standards of the Pharmaceutical Industry.
Learn more about each individual product by clicking on its name in the pipeline.
| Products Indication | Discovery | Preclinical | Phase I | Phase II | Deal |
|---|---|---|---|---|---|
| Metabolic Syndrome Program | |||||
| MPM-FB036 Weight Management | |||||
| MPM-SL0905 Hyperlipidemia | |||||
| MPM-FL0507 Hyperglycemia | |||||
| Immunotherapy Program | |||||
| MPM-PC010 Immune Stimulation | |||||
| MPM-DM0809 Skin Diseases | |||||
| MPM-TH50907 Wasting Syndrome AIDS | |||||
| MPM-TH21007 Autoimmune Diseases | |||||
| Gastrointestinal Program | |||||
| MPM-R14HOO Intestinal Inflammation | |||||
| Cancer Program | |||||
| ProfilActis Cancer Vaccine | |||||

